cute kidney injury (AKI) or chronic kidney disease (CKD), including end-stage renal disease (ESRD), requiring continuous renal replacement therapy (CRRT)
Conditions
Interventions
For patients requiring CRRT, hemofilters with cellulose triacetate (CTA) membranes were used for the first and second day of treatment.
For patients requiring CRRT, hemofilters with polysulfone (PS) m
Sponsors
Japanese Red Cross Osaka Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study population consisted of patients admitted to the intensive care unit of our hospital between June 2023 and September 2024, for whom the attending intensivist or primary physician determined that continuous renal replacement therapy (CRRT) was required.
Exclusion criteria
Exclusion criteria: Patients meeting any of the following criteria were excluded from the study: Presence of significant coagulation abnormalities due to hematologic disorders. Use of a hemofilter other than the assigned membrane material during the first or second CRRT session. Circuit clotting caused by prolonged troubleshooting, such as device malfunction or inadequate blood flow. Missing data regarding patient background or CRRT treatment conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of this study was the cumulative circuit survival rate at 48 hours, analyzed using the Kaplan-Meier method. | — |
Countries
Japan
Contacts
Public Contacttaro shimomura
Japanese Red Cross Osaka Hospital Department of Clinical Engineering
Outcome results
None listed